{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:15:14Z","timestamp":1789398914278,"version":"build-2803163510"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Cardiogenic shock (CS) is the leading cause of death in patients with acute myocardial infarction (AMI) despite advances in care. This study aims to derive and validate a risk score for in-hospital development of CS in patients with AMI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we used the Improving Care for Cardiovascular Disease in China\u2013Acute Coronary Syndrome (CCC\u2013ACS) registry of 76,807 patients for model development and internal validation. These patients came from 158 tertiary hospitals and 82 secondary hospitals between 2014 and 2019, presenting AMI without CS upon admission. The eligible patients with AMI were randomly assigned to derivation (<jats:italic>n<\/jats:italic> = 53,790) and internal validation (<jats:italic>n<\/jats:italic> = 23,017) cohorts. Another cohort of 2,205 patients with AMI between 2014 and 2016 was used for external validation. Based on the identified predictors for in-hospital CS, a new point-based CS risk scheme, referred to as the CCC\u2013ACS CS score, was developed and validated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 866 (1.1%) and 39 (1.8%) patients subsequently developed in-hospital CS in the CCC\u2013ACS project and external validation cohort, respectively. The CCC\u2013ACS CS score consists of seven variables, including age, acute heart failure upon admission, systolic blood pressure upon admission, heart rate, initial serum creatine kinase-MB level, estimated glomerular filtration rate, and mechanical complications. The area under the curve for in-hospital development of CS was 0.73, 0.71, and 0.85 in the derivation, internal validation and external validation cohorts, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This newly developed CCC\u2013ACS CS score can quantify the risk of in-hospital CS for patients with AMI, which may help in clinical decision making.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Trial Registration<\/jats:title><jats:p><jats:ext-link>www.ClinicalTrials.gov<\/jats:ext-link>, identifier: NCT02306616.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.793497","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T10:29:14Z","timestamp":1646389754000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A Risk Stratification Scheme for In-Hospital Cardiogenic Shock in Patients With Acute Myocardial Infarction"],"prefix":"10.3389","volume":"9","author":[{"given":"Jun-qing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Sidney C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-biao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-leng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-chen","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Wah","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-qing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e7293","DOI":"10.1161\/CIRCINTERVENTIONS.118.007293","article-title":"Twenty-year trends in the incidence and outcome of cardiogenic shock in AMIS plus registry","volume":"12","author":"Hunziker","year":"2019","journal-title":"Circ Cardiovasc Interv."},{"key":"B2","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.amjmed.2018.03.004","article-title":"Diabetes mellitus and cardiogenic shock complicating acute myocardial infarction","volume":"131","author":"Echouffo-Tcheugui","year":"2018","journal-title":"Am J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00392-017-1192-0","article-title":"Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry","volume":"107","author":"Backhaus","year":"2018","journal-title":"Clin Res Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCOUTCOMES.115.002359","article-title":"Decade-long trends (2001\u20132011) in the incidence and hospital death rates associated with the in-hospital development of cardiogenic shock after acute myocardial infarction","volume":"9","author":"Goldberg","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"B5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","article-title":"Cardiogenic shock: current concepts and improving outcomes","volume":"117","author":"Reynolds","year":"2008","journal-title":"Circulation."},{"key":"B6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/eurheartj\/eht248","article-title":"Mechanical circulatory support in cardiogenic shock","volume":"35","author":"Werdan","year":"2014","journal-title":"Eur Heart J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e590","DOI":"10.1161\/JAHA.113.000590","article-title":"Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States","volume":"3","author":"Kolte","year":"2014","journal-title":"J Am Heart Assoc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e21061","DOI":"10.1161\/JAHA.121.021061","article-title":"Fifteen-year trends in incidence of cardiogenic shock hospitalization and in-hospital mortality in the United States","volume":"10","author":"Osman","year":"2021","journal-title":"J Am Heart Assoc."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/ehf2.13202","article-title":"Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock","volume":"8","author":"Schrage","year":"2021","journal-title":"ESC Heart Fail."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jcin.2021.02.021","article-title":"Multivessel versus culprit-vessel percutaneous coronary intervention in patients with non-ST-segment elevation myocardial infarction and cardiogenic shock","volume":"14","author":"Omer","year":"2021","journal-title":"JACC Cardiovasc Interv."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/17482940601178039","article-title":"Causes of death and re-hospitalization in cardiogenic shock","volume":"9","author":"Jeger","year":"2007","journal-title":"Acute Card Care."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1093\/eurheartj\/ehp292","article-title":"Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials","volume":"30","author":"Cheng","year":"2009","journal-title":"Eur Heart J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0735-1097(00)00814-7","article-title":"Platelet glycoprotein IIb\/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation","volume":"36","author":"Hasdai","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0735-1097(99)00508-2","article-title":"Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction","volume":"35","author":"Hasdai","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1093\/eurheartj\/ehy127","article-title":"Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score","volume":"39","author":"Auffret","year":"2018","journal-title":"Eur Heart J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ahj.2016.06.005","article-title":"Rationale and design of the improving Care for Cardiovascular Disease in China (CCC) project: a national effort to prompt quality enhancement for acute coronary syndrome","volume":"179","author":"Hao","year":"2016","journal-title":"Am Heart J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.114.014508","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD group","volume":"131","author":"Collins","year":"2015","journal-title":"Circulation."},{"key":"B19","first-page":"98","article-title":"Chinese guidelines for the diagnosis and treatment of heart failure 2014","volume":"42","year":"2014","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi."},{"key":"B20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11886-019-1102-3","article-title":"Update in the management of acute coronary syndrome patients with cardiogenic shock","volume":"21","author":"Bagai","year":"2019","journal-title":"Curr Cardiol Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/17482941003637106","article-title":"Predictors and in-hospital outcomes of cardiogenic shock on admission in patients with acute coronary syndromes admitted to hospitals without on-site invasive facilities","volume":"12","author":"Dziewierz","year":"2010","journal-title":"Acute Card Care."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/CCM.0b013e3181eaaf2a","article-title":"Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 percutaneous coronary intervention trial","volume":"38","author":"Jarai","year":"2010","journal-title":"Crit Care Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0195-668X(02)00429-3","article-title":"Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development","volume":"24","author":"Lindholm","year":"2003","journal-title":"Eur Heart J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"618","DOI":"10.7326\/0003-4819-149-9-200811040-00005","article-title":"Ten-year trends in the incidence and treatment of cardiogenic shock","volume":"149","author":"Jeger","year":"2008","journal-title":"Ann Intern Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijcard.2006.11.102","article-title":"Cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with percutaneous coronary intervention: related factors","volume":"123","author":"Conde-Vela","year":"2007","journal-title":"Int J Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ccl.2013.07.004","article-title":"Mechanical complications of acute myocardial infarction","volume":"31","author":"Kutty","year":"2013","journal-title":"Cardiol Clin."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.jcin.2019.04.039","article-title":"Temporal trends and outcomes of mechanical complications in patients with acute myocardial infarction","volume":"12","author":"Elbadawi","year":"2019","journal-title":"JACC Cardiovasc Interv."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.793497\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T10:29:19Z","timestamp":1646389759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.793497\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":27,"alternative-id":["10.3389\/fcvm.2022.793497"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.793497","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"article-number":"793497"}}